{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/MRVI/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-09-29T05:34:37.676Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":2035,"canonical_name":"MARAVAI LIFESCIENCES HOLDINGS, INC.","cik":"0001823239","uei":null,"lei":null,"duns":null,"ticker":"MRVI"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":17},"count":17,"timeline":[{"ts":"2026-08-10","kind":"sec.insider.f","reporter":"Brust Bernd","title":"Chief Executive Officer","shares":29250,"price_per_share":6.23,"usd_value":182228,"security_title":"Class A Common Stock","importance":15.1822275},{"ts":"2026-06-30","kind":"sec.insider.f","reporter":"Asarpota Rajesh","title":"Chief Financial Officer","shares":65584,"price_per_share":6.39,"usd_value":419082,"security_title":"Class A Common Stock","importance":15.41908176},{"ts":"2026-06-23","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — MILLENNIUM MANAGEMENT LLC — 2026-06-23","url_slug":"/sec/cik-0001273087/schedule-13g/0001104659-26-076907","accession_number":"0001104659-26-076907","importance":55},{"ts":"2026-06-10","kind":"sec.form144","reporter":"ORESHACK KURT","title":"Officer","shares":25000,"usd_value":127500,"security_title":"Class A","approx_sale_date":"2026-06-10","accession_number":"0001959173-26-004507","importance":40.0255},{"ts":"2026-06-10","kind":"sec.insider.s","reporter":"ORESHACK KURT","title":"General Counsel","shares":25000,"price_per_share":5.1,"usd_value":127500,"security_title":"Class A Common Stock","importance":35.1275},{"ts":"2026-06-10","kind":"sec.filing","form_type":"144","title":"144 — MARAVAI LIFESCIENCES HOLDINGS, INC. — 2026-06-10","url_slug":"/sec/cik-0001823239/144/0001959173-26-004507","accession_number":"0001959173-26-004507","importance":30},{"ts":"2026-06-10","kind":"sec.filing","form_type":"4","title":"4 — MARAVAI LIFESCIENCES HOLDINGS, INC. — 2026-06-10","url_slug":"/sec/cik-0001823239/4/0001832579-26-000007","accession_number":"0001832579-26-000007","importance":30},{"ts":"2026-06-09","kind":"sec.form144","reporter":"ORESHACK KURT","title":"Officer","shares":25000,"usd_value":126500,"security_title":"Class A","approx_sale_date":"2026-06-09","accession_number":"0001959173-26-004463","importance":40.0253},{"ts":"2026-06-09","kind":"sec.insider.s","reporter":"ORESHACK KURT","title":"General Counsel","shares":25000,"price_per_share":5.06,"usd_value":126500,"security_title":"Class A Common Stock","importance":35.1265},{"ts":"2026-06-09","kind":"sec.filing","form_type":"144","title":"144 — MARAVAI LIFESCIENCES HOLDINGS, INC. — 2026-06-09","url_slug":"/sec/cik-0001823239/144/0001959173-26-004463","accession_number":"0001959173-26-004463","importance":30},{"ts":"2026-06-09","kind":"sec.insider.g","reporter":"LUCIER GREGORY T","title":null,"shares":46293,"price_per_share":0,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-06-09","kind":"sec.insider.g","reporter":"LUCIER GREGORY T","title":null,"shares":46293,"price_per_share":0,"usd_value":0,"security_title":"Class A Common Stock","importance":15},{"ts":"2026-06-08","kind":"sec.insider.f","reporter":"Brust Bernd","title":"Chief Executive Officer","shares":351001,"price_per_share":5.02,"usd_value":1762025,"security_title":"Class A Common Stock","importance":16.76202502},{"ts":"2026-06-03","kind":"sec.filing","form_type":"8-K","title":"8-K — MARAVAI LIFESCIENCES HOLDINGS, INC. — 2026-06-03","url_slug":"/sec/cik-0001823239/8-k/0001823239-26-000049","accession_number":"0001823239-26-000049","importance":35},{"ts":"2026-05-15","kind":"sec.filing","form_type":"SCHEDULE 13G/A","title":"SCHEDULE 13G/A — 12 West Capital Management LP — 2026-05-15","url_slug":"/sec/cik-0001540531/schedule-13g-a/0000902664-26-002470","accession_number":"0000902664-26-002470","importance":30},{"ts":"2026-05-12","kind":"sec.13dg","reporter":"MILLENNIUM MANAGEMENT LLC","shares":7228864,"percent_of_class":4.9,"security_title":"SCHEDULE 13G","accession_number":"0001104659-26-059524","excerpt":null,"importance":55},{"ts":"2026-05-08","kind":"sec.filing","form_type":"10-Q","title":"10-Q — MARAVAI LIFESCIENCES HOLDINGS, INC. — 2026-05-08","url_slug":"/sec/cik-0001823239/10-q/0001823239-26-000024","accession_number":"0001823239-26-000024","importance":45}]}